| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | Feb 5, 2025 | Zentalis Pharmaceuticals, Inc. | PAO and Interim PFO | Sell | 90.0 | +155,971 | 460.70% | ✗ | $4.5K |
| Oct 4, 2024 | Oct 4, 2024 | Zentalis Pharmaceuticals, Inc. | Principal Accounting Officer | Sell | 42.5 | -1,603 | -4.52% | ✓ | $5.1K |